{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T13:57:59Z","timestamp":1773323879771,"version":"3.50.1"},"reference-count":45,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.3892\/etm.2012.709","type":"journal-article","created":{"date-parts":[[2012,9,17]],"date-time":"2012-09-17T10:51:23Z","timestamp":1347879083000},"page":"972-976","source":"Crossref","is-referenced-by-count":16,"title":["Relationship of \u03b1-fetoprotein levels and development of hepatocellular carcinoma in hepatitis C patients with liver cirrhosis"],"prefix":"10.3892","volume":"4","author":[{"given":"NAOTA","family":"TAURA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SACHIKO","family":"FUKUDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TATSUKI","family":"ICHIKAWA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HISAMITSU","family":"MIYAAKI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HIDETAKA","family":"SHIBATA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKUYA","family":"HONDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TOHEI","family":"YAMAGUCHI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YOKO","family":"KUBOTA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHINJIRO","family":"UCHIDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YASUHIRO","family":"KAMO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EMI","family":"YOSHIMURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HAJIME","family":"ISOMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKEHIRO","family":"MATSUMOTO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FUMINAO","family":"TAKESHIMA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAKUYA","family":"TSUTSUMI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHOTARO","family":"TSURUTA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KAZUHIKO","family":"NAKAO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2012,9,17]]},"reference":[{"key":"key20180108121557_b1-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1001\/archinte.160.21.3227","article-title":"Risk factors for the rising rates of primary liver cancer in the United States","volume":"160","author":"El-Serag","year":"2000","journal-title":"Arch Intern Med"},{"key":"key20180108121557_b2-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"87vi","DOI":"10.1016\/S1089-3261(05)70155-0","article-title":"Epidemiology of hepatocellular carcinoma","volume":"5","author":"El-Serag","year":"2001","journal-title":"Clin Liver Dis"},{"key":"key20180108121557_b3-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/hep.1840360621","article-title":"Extrahepatic manifestations of hepatitis C among United States male veterans","volume":"36","author":"El-Serag","year":"2002","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"key20180108121557_b4-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1002\/hep.1840360710","article-title":"Hepatocellular carcinoma and hepatitis C in the United States","volume":"36","author":"El-Serag","year":"2002","journal-title":"Hepatology"},{"issue":"Suppl 2","key":"key20180108121557_b5-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1097\/00004836-200211002-00002","article-title":"Hepatocellular carcinoma: an epidemiologic view","volume":"35","author":"El-Serag","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"key20180108121557_b6-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00004836-200209000-00013","article-title":"Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States","volume":"35","author":"Hassan","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"key20180108121557_b7-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"key20180108121557_b8-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000048269","article-title":"Characteristics of hepatocellular carcinoma in Japan","volume":"62","author":"Kiyosawa","year":"2002","journal-title":"Oncology"},{"key":"key20180108121557_b9-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ijc.1456","article-title":"International trends and patterns of primary liver cancer","volume":"94","author":"McGlynn","year":"2001","journal-title":"Int J Cancer"},{"key":"key20180108121557_b10-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1053\/j.gastro.2004.09.011","article-title":"Primary liver cancer: worldwide incidence and trends","volume":"127","author":"Bosch","year":"2004","journal-title":"Gastroenterology"},{"key":"key20180108121557_b11-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/jmv.1890400212","article-title":"Changes in the prevalence of hepatitis B and C infection in patients with hepatocellular carcinoma in the Nagasaki Prefecture, Japan","volume":"40","author":"Hamasaki","year":"1993","journal-title":"J Med Virol"},{"key":"key20180108121557_b12-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1002\/1097-0142(19941015)74:8<2234::AID-CNCR2820740805>3.0.CO;2-6","article-title":"Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses","volume":"74","author":"Kato","year":"1994","journal-title":"Cancer"},{"key":"key20180108121557_b13-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/hep.1840220403","article-title":"Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan","volume":"22","author":"Shiratori","year":"1995","journal-title":"Hepatology"},{"key":"key20180108121557_b14-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1002\/(SICI)1097-0142(19971201)80:11<2060::AID-CNCR4>3.0.CO;2-0","article-title":"Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?","volume":"80","author":"Shiratori","year":"1997","journal-title":"Cancer"},{"key":"key20180108121557_b15-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1872-034X.2007.00073.x","article-title":"Efficacy of low dose long-term interferon monotherapy in aged patients with chronic hepatitis C genotype 1 and its relation to alpha-fetoprotein: A pilot study","volume":"37","author":"Nomura","year":"2007","journal-title":"Hepatol Res"},{"key":"key20180108121557_b16-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/hep.1840120625","article-title":"Alpha-fetoprotein: reevaluation in hepatology","volume":"12","author":"Taketa","year":"1990","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"key20180108121557_b17-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1002\/hep.510260706","article-title":"Hepatitis C and hepatocellular carcinoma","volume":"26","author":"Di Bisceglie","year":"1997","journal-title":"Hepatology"},{"key":"key20180108121557_b18-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2005-871194","article-title":"Hepatocellular carcinoma: epidemiology, risk factors, and screening","volume":"25","author":"Sherman","year":"2005","journal-title":"Semin Liver Dis"},{"key":"key20180108121557_b19-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.clon.2006.12.005","article-title":"Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study","volume":"19","author":"Rodr\u00edguez-D\u00edaz","year":"2007","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"key20180108121557_b20-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.20933","article-title":"American Association for the Study of Liver Disease: Management of hepatocellular carcinoma","volume":"42","author":"Bruix","year":"2005","journal-title":"Hepatology"},{"key":"key20180108121557_b21-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM199109053251002","article-title":"Hepatocellular carcinoma in Italian patients with cirrhosis","volume":"325","author":"Colombo","year":"1991","journal-title":"N Engl J Med"},{"key":"key20180108121557_b22-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM199306243282501","article-title":"Risk factors for hepatocellular carcinoma among patients with chronic liver disease","volume":"328","author":"Tsukuma","year":"1993","journal-title":"N Engl J Med"},{"key":"key20180108121557_b23-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/hep.1840190111","article-title":"Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma","volume":"19","author":"Oka","year":"1994","journal-title":"Hepatology"},{"key":"key20180108121557_b24-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/hep.510230527","article-title":"Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis","volume":"23","author":"Ganne-Carri\u00e9","year":"1996","journal-title":"Hepatology"},{"key":"key20180108121557_b25-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/j.1572-0241.2001.03780.x","article-title":"Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patients","volume":"96","author":"Sangiovanni","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"key20180108121557_b26-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00535-010-0293-6","article-title":"Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus","volume":"46","author":"Tateyama","year":"2011","journal-title":"J Gastroenterol"},{"key":"key20180108121557_b27-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0303-7207(96)03762-8","article-title":"Alpha-fetoprotein derived synthetic peptides: assay of an estrogen-modifying regulatory segment","volume":"118","author":"Mizejewski","year":"1996","journal-title":"Mol Cell Endocrinol"},{"key":"key20180108121557_b28-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/ijc.24272","article-title":"Alpha fetoprotein is a novel protein-binding partner for caspase-3 and blocks the apoptotic signaling pathway in human hepatoma cells","volume":"124","author":"Li","year":"2009","journal-title":"Int J Cancer"},{"key":"key20180108121557_b29-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/ijc.25373","article-title":"Alpha-fetoprotein: a new member of intra-cellular signal molecules in regulation of the PI3K\/AKT signaling in human hepatoma cell lines","volume":"128","author":"Li","year":"2011","journal-title":"Int J Cancer"},{"key":"key20180108121557_b30-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.canlet.2008.06.017","article-title":"Silencing alpha-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell","volume":"271","author":"Yang","year":"2008","journal-title":"Cancer Lett"},{"key":"key20180108121557_b31-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.canlet.2009.05.014","article-title":"Cytoplasmic alpha-fetoprotein functions as a co-repressor in RA-RAR signaling to promote the growth of human hepatoma Bel 7402 cells","volume":"285","author":"Li","year":"2009","journal-title":"Cancer Lett"},{"key":"key20180108121557_b32-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"174","DOI":"10.7326\/0003-4819-131-3-199908030-00003","article-title":"Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group Inhibition of Hepatocarcinogenesis by Interferon Therapy","volume":"131","author":"Yoshida","year":"1999","journal-title":"Ann Intern Med"},{"issue":"Suppl 1","key":"key20180108121557_b33-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","article-title":"Hepatocellular carcinoma in cirrhosis: incidence and risk factors","volume":"127","author":"Fattovich","year":"2004","journal-title":"Gastroenterology"},{"key":"key20180108121557_b34-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0140-6736(95)91739-X","article-title":"Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis","volume":"346","author":"Nishiguchi","year":"1995","journal-title":"Lancet"},{"issue":"Suppl 1","key":"key20180108121557_b35-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000111703","article-title":"Long-term effects of interferon-based therapy for chronic hepatitis C","volume":"72","author":"Yu","year":"2007","journal-title":"Oncology"},{"key":"key20180108121557_b36-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-129-2-199807150-00005","article-title":"Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka Hepatocellular Carcinoma Prevention Study Group","volume":"129","author":"Imai","year":"1998","journal-title":"Ann Intern Med"},{"key":"key20180108121557_b37-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/hep.510270529","article-title":"Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group","volume":"27","author":"Kasahara","year":"1998","journal-title":"Hepatology"},{"key":"key20180108121557_b38-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/hep.510290439","article-title":"Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis","volume":"29","author":"Ikeda","year":"1999","journal-title":"Hepatology"},{"key":"key20180108121557_b39-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1386-6346(02)00016-5","article-title":"Transient biochemical response in interferon therapy decreases the development of hepatocellular carcinoma for five years and improves the long-term survival of chronic hepatitis C patients","volume":"23","author":"Okanoue","year":"2002","journal-title":"Hepatol Res"},{"key":"key20180108121557_b40-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jac\/dkh031","article-title":"Interferon therapy as chemoprevention of hepatocarcinogenesis in patients with chronic hepatitis C","volume":"53","author":"Hino","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"key20180108121557_b41-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/hep.510290616","article-title":"Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alpha-2b versus no treatment","volume":"29","author":"Valla","year":"1999","journal-title":"Hepatology"},{"key":"key20180108121557_b42-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2174\/1381612043384321","article-title":"The impact of antiviral treatments on the course of chronic hepatitis C: an evidence-based approach","volume":"10","author":"Camm\u00e0","year":"2004","journal-title":"Curr Pharm Des"},{"key":"key20180108121557_b43-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0016-5085(99)70402-6","article-title":"A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia","volume":"117","author":"Shiffman","year":"1999","journal-title":"Gastroenterology"},{"key":"key20180108121557_b44-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s10620-006-3211-2","article-title":"A decrease in AFP level related to administration of interferon in patients with chronic hepatitis C and a high level of AFP","volume":"51","author":"Murashima","year":"2006","journal-title":"Dig Dis Sci"},{"key":"key20180108121557_b45-etm-04-06-0972","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/hep.510290624","article-title":"Interferon alpha receptor expression and growth inhibition by interferon alpha in human liver cancer cell lines","volume":"29","author":"Yano","year":"1999","journal-title":"Hepatology"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2012.709\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:49:14Z","timestamp":1744152554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2012.709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,17]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,9,17]]},"published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.3892\/etm.2012.709"],"URL":"https:\/\/doi.org\/10.3892\/etm.2012.709","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,17]]}}}